China Merchants Health logo

China Merchants Health

Asia, Hunan, China, Nanshan

Description

China Merchants Health is a comprehensive enterprise with a diverse range of businesses.

Investor Profile

China Merchants Health has made 3 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Series B (67%)
  • Series C (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Life Science
  • Medical Device
  • Genetics
  • Manufacturing
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Merchants Health frequently co-invest with?

GreatWall Fund
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Industrial Asset Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CD Capital
Asia, Zhejiang, China, Ningbo
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
E Fund Management Co.,LTD.
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
China Reform Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by China Merchants Health?

Porton Advanced Solutions

Suzhou, Jiangsu, China

Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

BiotechnologyGeneticsManufacturingPharmaceuticalTherapeutics
Series BAug 21, 2022
Amount Raised: $80,000,000
Wellgrow Technology

Shenzhen, Guangdong, China

Wellgrow Technology is a developer of in vitro diagnostic medical equipment and reagents.

BiotechnologyLife ScienceMedical Device
Series BJan 25, 2022
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738